Colin Bristow's Stock Ratings

UBS Analyst

Colin Bristow is an analyst at UBS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/31/2024

Overall Average Return

-3.87%

Smart Score

48.8%

Overall Average Return Percentile

28th

Number of Ratings

52
Buy NowGet Alert
07/31/2024MRKBuy Now
Merck & Co
$112.8825.8%$148 → $142MaintainsBuyGet Alert
07/31/2024PFEBuy Now
Pfizer
$30.800.67%$30 → $31MaintainsNeutralGet Alert
05/03/2024AMGNBuy Now
Amgen
$334.82-8.31%$284 → $307MaintainsNeutralGet Alert
04/17/2024REGNBuy Now
Regeneron Pharmaceuticals
$1.09K1.09%$1090 → $1099MaintainsBuyGet Alert
04/17/2024AMGNBuy Now
Amgen
$334.82-15.18%$314 → $284MaintainsNeutralGet Alert
04/17/2024BIIBBuy Now
Biogen
$217.72-1.71%$250 → $214MaintainsNeutralGet Alert
04/17/2024GILDBuy Now
Gilead Sciences
$76.92-2.5%$81 → $75MaintainsNeutralGet Alert
04/17/2024VRTXBuy Now
Vertex Pharmaceuticals
$500.54-6.9%$498 → $466MaintainsBuyGet Alert
03/28/2024ENGNBuy Now
enGene Holdings
$10.00270% → $37Initiates → BuyGet Alert
03/01/2024RCKTBuy Now
Rocket Pharmaceuticals
$24.68118.8%$56 → $54MaintainsBuyGet Alert
03/01/2024SRPTBuy Now
Sarepta Therapeutics
$143.3116.53%$164 → $167MaintainsBuyGet Alert
02/21/2024BTAIBuy Now
BioXcel Therapeutics
$1.13253.98%$9 → $4DowngradeBuy → NeutralGet Alert
02/16/2024BIIBBuy Now
Biogen
$217.7214.83%$276 → $250MaintainsNeutralGet Alert
02/02/2024MRKBuy Now
Merck & Co
$112.8831.11%$135 → $148MaintainsBuyGet Alert
01/29/2024AMGNBuy Now
Amgen
$334.82-6.22%$315 → $314MaintainsNeutralGet Alert
01/25/2024BIIBBuy Now
Biogen
$217.7226.77%$311 → $276DowngradeBuy → NeutralGet Alert
01/24/2024BIIBBuy Now
Biogen
$217.7226.77% → $276DowngradeBuy → NeutralGet Alert
12/14/2023PFEBuy Now
Pfizer
$30.80-12.32%$34 → $27MaintainsNeutralGet Alert
12/01/2023IMVTBuy Now
Immunovant
$28.2098.58%$55 → $56MaintainsBuyGet Alert
11/02/2023AMGNBuy Now
Amgen
$334.82-19.96%$272 → $268MaintainsNeutralGet Alert
10/20/2023PFEBuy Now
Pfizer
$30.8010.41%$36 → $34AssumesNeutral → NeutralGet Alert
10/13/2023IMVTBuy Now
Immunovant
$28.2095.04%$18 → $55UpgradeNeutral → BuyGet Alert
10/04/2023ALXOBuy Now
ALX Oncology Holdings
$4.96444.35%$29 → $27MaintainsBuyGet Alert
07/24/2023VRTXBuy Now
Vertex Pharmaceuticals
$500.54-15.29%$399 → $424MaintainsBuyGet Alert
07/21/2023CCCBuy Now
Carlyle Commodities
——$22 → $20MaintainsBuyGet Alert
05/15/2023SRPTBuy Now
Sarepta Therapeutics
$143.3120.72%$160 → $173MaintainsBuyGet Alert
05/02/2023VRTXBuy Now
Vertex Pharmaceuticals
$500.54-20.29%$375 → $399MaintainsBuyGet Alert
03/15/2023ALXOBuy Now
ALX Oncology Holdings
$4.96484.68%$31 → $29MaintainsBuyGet Alert
02/16/2023BIIBBuy Now
Biogen
$217.7256.17%$337 → $340MaintainsBuyGet Alert
02/08/2023VRTXBuy Now
Vertex Pharmaceuticals
$500.54-25.08%$373 → $375MaintainsBuyGet Alert
01/30/2023VRTXBuy Now
Vertex Pharmaceuticals
$500.54-25.48%$342 → $373MaintainsBuyGet Alert
01/26/2023PFEBuy Now
Pfizer
$30.8052.62%$55 → $47DowngradeBuy → NeutralGet Alert
12/16/2022SRPTBuy Now
Sarepta Therapeutics
$143.3110.25%$100 → $158UpgradeNeutral → BuyGet Alert
12/15/2022LLYBuy Now
Eli Lilly
$798.84-47.42%$428 → $420MaintainsBuyGet Alert
12/08/2022OMERBuy Now
Omeros
$5.51-63.7%$12 → $2DowngradeBuy → NeutralGet Alert
10/21/2022VRTXBuy Now
Vertex Pharmaceuticals
$500.54-32.67%$335 → $337MaintainsBuyGet Alert
10/18/2022PROKBuy Now
ProKidney
$2.38656.3% → $18Initiates → BuyGet Alert
10/06/2022BIIBBuy Now
Biogen
$217.7241.93%$238 → $309MaintainsBuyGet Alert
09/27/2022RCKTBuy Now
Rocket Pharmaceuticals
$24.68151.22%$68 → $62MaintainsBuyGet Alert
09/26/2022IMVTBuy Now
Immunovant
$28.20-82.27%$7 → $5DowngradeBuy → NeutralGet Alert
08/01/2022ABBVBuy Now
AbbVie
$184.88-21.03%$154 → $146MaintainsNeutralGet Alert
07/28/2022BMYBuy Now
Bristol-Myers Squibb
$47.9856.33%$73 → $75MaintainsNeutralGet Alert
07/18/2022MRKBuy Now
Merck & Co
$112.88-13.18%$76 → $98MaintainsNeutralGet Alert
04/27/2022VRTXBuy Now
Vertex Pharmaceuticals
$500.54-35.67%$325 → $322MaintainsBuyGet Alert
04/18/2022CCCCBuy Now
C4 Therapeutics
$6.43304.35%$64 → $26MaintainsBuyGet Alert
04/13/2022VRTXBuy Now
Vertex Pharmaceuticals
$500.54-35.07%$258 → $325MaintainsBuyGet Alert
02/28/2022ABBVBuy Now
AbbVie
$184.88-20.49%$129 → $147DowngradeBuy → NeutralGet Alert
02/16/2022BTAIBuy Now
BioXcel Therapeutics
$1.132112.39%$88 → $25MaintainsBuyGet Alert
12/13/2021MRKBuy Now
Merck & Co
$112.88-32.67%—DowngradeBuy → NeutralGet Alert
12/13/2021PFEBuy Now
Pfizer
$30.8094.84%—UpgradeNeutral → BuyGet Alert
05/12/2021VRTXBuy Now
Vertex Pharmaceuticals
$500.54-44.26%$278 → $279MaintainsBuyGet Alert
11/20/2020VRTXBuy Now
Vertex Pharmaceuticals
$500.54-42.46%$287 → $288MaintainsBuyGet Alert